Identification of genetic alterations in malignant mesothelioma and the development of new molecular diagnostic tools
Project/Area Number |
22300338
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Tumor diagnosis
|
Research Institution | Aichi Cancer Center Research Institute |
Principal Investigator |
SEKIDO Yoshitaka 愛知県がんセンター(研究所), 分子腫瘍学部, 部長 (00311712)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2012: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2011: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2010: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
|
Keywords | 中皮腫 / がん抑制遺伝子 / がん遺伝子 / ゲノム異常 / シグナル伝達 / 癌 / ゲノム |
Research Abstract |
We identified that the LATS2 gene is a novel tumor suppressor gene of malignant mesothelioma (MM) and that LATS2 is inactivated in around 20% of MM cases. Inactivation of NF2 and/or LATS2 results in dysregulation of the Hippo tumor suppressive signaling cascade in MM cells. We found that Hippo pathway inactivation causes YAP activation and enhances transcription of the cyclin D and CTGF genes, which induces a more malignant phenotype of MM.
|
Report
(4 results)
Research Products
(37 results)
-
-
[Journal Article] Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.2012
Author(s)
Horio M, Sato M, Takeyama Y, Elshazley M, Yamashita R, Hase T, Yoshida K, Usami N, Yokoi K, Sekido Y, Kondo M, Toyokuni S, Gazdar AF, Minna JD, Hasegawa Y
-
Journal Title
Ann Surg Oncol.
Volume: 19 Supple3
DOI
Related Report
Peer Reviewed
-
[Journal Article] YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle promoting genes.2012
Author(s)
Mizuno T, Murakami H, Fujii M, Ishiguro F, Tanaka I, Kondo Y, Akatsuka S, Toyokuni S, Yokoi K, Osada H, Sekido Y
-
Journal Title
Oncogene
Volume: 31
Pages: 5117-22
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth2012
Author(s)
Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, Hida T, Tsujimura T, Osada H, Sekido Y.
-
Journal Title
The Journal of Experimental Medicine
Volume: VOL.209(3)
Pages: 479-494
DOI
Related Report
Peer Reviewed
-
[Journal Article] The circadian clock gene BMAL1 is a novel therapeutic target for malignant mesothelioma.2012
Author(s)
Elshazley M, Sato M, Hase T, Yamashita R, Yoshida K, Toyokuni S, Ishiguro F, Osada H, Sekido Y, Yokoi K, Usami N, Shames DS, Kondo M, Gazdar AF, Minna JD, Hasegawa Y
-
Journal Title
Int J Cancer.
Volume: 131
Pages: 2820-2831
DOI
Related Report
Peer Reviewed
-
[Journal Article] Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer.2012
Author(s)
Liu Y, Izumiya M, Abe K, Ochiai M, Jiang L, Nagai H, Okazaki Y, Murakami H, Sekido Y, Arai E, Kanai Y, Hino O, Takahashi T, Nakagama H, Toyokuni S
-
Journal Title
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] LATS2 is a tumor suppressor gene of malignant mesothelioma.2011
Author(s)
Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, Toyokuni S, Osada H, Sekido Y
-
Journal Title
Cancer Res
Volume: 71
Pages: 873-83
Related Report
-
[Journal Article] 5-Aminolevulinic acid-induced fluorescence diagnosis of pleural malignant tumor.2011
Author(s)
Ali AH, Takizawa H, Kondo K, Matsuoka H, Toba H, Nakagawa Y, Kenzaki K, Sakiyama S, Kakiuchi S, Sekido Y, Sone S, Tangoku A
-
Journal Title
Lung Cancer
Volume: 74
Pages: 48-54
DOI
Related Report
-
-
[Journal Article] Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.2010
Author(s)
Tajima K, Ohashi R, Sekido Y, Hida T, Nara T, Hashimoto M, Iwakami S, Minakata K, Yae T, Takahashi F, Saya H, Takahashi K
-
Journal Title
Oncogene
Volume: 29
Pages: 1941-51
DOI
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Inactivation of LATS2 indicates frequent dysregulation of the Merlin-Hippo signaling pathway in malignant mesothelioma.2010
Author(s)
Sekido Y, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, Toyokuni S, Osada H, Murakami H.
Organizer
10th International Conference of International Mesothelioma Interest Group (iMig)
Place of Presentation
京都国際会館(京都)
Year and Date
2010-09-02
Related Report
-
-
-
-
-
-
-
-